Skip to main content
The Journal of Veterinary Medical Science logoLink to The Journal of Veterinary Medical Science
. 2022 Aug 25;84(10):1324–1327. doi: 10.1292/jvms.22-0287

Leptospirosis with multiple organ dysfunction in a mongoose-scat-detection dog infected with Leptospira interrogans serogroup Hebdomadis, Okinawa, Japan

Tetsuya KAKITA 1,*, Maki YAMAGISHI 2, Sugao OSHIRO 2, Chisako OYAKAWA 3, Takashi NAGAMINE 4, Tsuyoshi KUDEKEN 1, Hisako KYAN 1, Nobuo KOIZUMI 5
PMCID: PMC9586021  PMID: 36002297

Abstract

A 2-year-old male mongoose-scat-detection dog was diagnosed with leptospirosis by urine PCR. The patient developed acute renal failure, hepatic dysfunction, and disseminated intravascular coagulation. Treatment with antibiotics was administered, including ampicillin and doxycycline, and supportive care management was provided. Seroconversion against serogroup Hebdomadis was observed on day 8. The leptospiral gene flaB was detected only in urine collected on day 1, from which Leptospira interrogans ST329 was identified by multilocus sequence typing using seven housekeeping genes. L. interrogans serogroup Hebdomadis ST329 has been isolated from mongooses and humans in Okinawa, Japan. This patient received early treatment with antibiotics, which may have contributed to the early recovery of renal function and removal of L. interrogans from kidney tissue.

Keywords: canine leptospirosis, disseminated intravascular coagulation, Leptospira interrogans serogroup Hebdomadis, mongoose-scat-detection dog, multilocus sequence typing


Leptospirosis is a zoonotic disease caused by infection with pathogenic spirochetes from the genus Leptospira, which affects a wide range of wild and domestic animals and humans [8]. The pathogenic Leptospira spp. can colonize the proximal renal tubules of reservoir animals and are excreted in urine [8]. Dogs are infected percutaneously or permucosally with Leptospira spp. through contact with the urine of infected animals or with soil or water contaminated with infected urine [8]. Clinical manifestations of canine leptospirosis can vary from subclinical and minimal clinical disease to severe disease involving kidney, liver, and pulmonary tissues, depending on the infecting Leptospira strain and host immune status triggered by previous vaccination or previous infection [2, 9, 12]. Since a high index of suspicion is required, canine leptospirosis remains a significant diagnostic challenge for veterinarians [2].

The genus Leptospira consists of 64 species divided into 24 serogroups and more than 300 serovars [8, 13]. Dogs are considered as maintenance hosts for L. interrogans serovar Canicola worldwide, and accidental infections with serovars/serogroups Australis, Autumnalis, Ballum, Canicola, Grippotyphosa, Hebdomadis, Icterohaemorrhagiae, Pomona, and Sejroe have been reported [6, 7, 12]. Prevalent Leptospira serovars among dog populations vary geographically depending on exposure to wild or domestic reservoir animals [12]. Although L. interrogans serogroup Hebdomadis has been isolated from dogs with acute illnesses [6, 7], detailed characteristics of clinical pictures of dogs infected with the Hebdomadis strains have not been reported. In this report, we describe the clinical symptoms, laboratory findings, and serological and molecular findings in a dog infected with L. interrogans serogroup Hebdomadis.

A 2-year-old male German Shepherd was presented to the Yambaru Animal Clinic in August 2021 with clinical signs of fever (39.3°C), diarrhea with hematochezia, vomiting, and dehydration. The owner reported that the patient had exhibited signs of malaise 1 day before the consultation. The patient was a detection dog for scats of small Indian mongoose and was engaged in mongoose exploration in the forest almost every day. The patient was vaccinated with an inactivated bivalent leptospirosis vaccine containing serovars Canicola and Icterohaemorrhagiae in May 2021. The patient returned home after subcutaneous administration of ampicillin (25 mg/kg), enrofloxacin (5 mg/kg), famotidine (1 mg/kg), metoclopramide (0.25 mg/kg), diphenhydramine (1 mg/kg), prednisolone (1 mg/kg), and a combination drug of glycyrrhizin, glycine, and cysteine (0.5 mL/kg).

The patient was brought to the clinic again on the next day (day 1) due to food refusal, abnormal urine color (orange-yellow), and vomiting. Body temperature measurement indicated that the patient was afebrile (38.4°C). The blood examination revealed leukocytosis (18,200/μL), neutrophilia (14,860/μL), monocytosis (2,130/μL), thrombocytopenia (35/μL), and decreased hematocrit (35.4%) (Table 1). In addition, serum biochemical examination suggested acute renal failure and hepatic dysfunction based on increased levels of serum creatinine (2.6 mg/dL), blood urea nitrogen (BUN, 53 mg/dL), serum symmetric dimethylarginine (SDMA, 21 μg/dL), serum total bilirubin (6.9 mg/dL), serum C-reactive protein (7 mg/dL), serum alanine aminotransaminase (237 IU/L), and serum alkaline phosphatase (1,225 IU/L). The blood coagulation test suggested disseminated intravascular coagulation (DIC) based on increases in activated partial thromboplastin time (36.7 sec), prothrombin time (8.4 sec), fibrinogen degradation product (27.3 μg/mL), D-Dimer (9.07 μg/mL), and thrombin–antithrombin complex (1 ng/mL). Leptospiral DNA was detected from urine by PCR performed by an outsourcing company (Neopark Okinawa Veterinary Laboratory, Okinawa, Japan) [11]. Based on clinical and laboratory findings and epidemiological information, the patient was diagnosed with leptospirosis. The patient was hospitalized and received intravenous administration of ampicillin. The supportive care management provided included subcutaneous administration of tranexamic acid, phytonadione, and folic acid; intravenous administration of diprophylline, maropitant, tiopronin, ulinastatin, and glutathione; and oral administration of ursodeoxycholic acid, benazepril, and camostat mesylate.

Table 1. The result of complete blood count, serum biochemical profile, blood coagulation test.

Laboratory examination Unit Nomal range Days

1 4 6 8 11 13 15 18 20 23 26 29 32 49 70 84
Complete blood count
White blood cell count K/μL 5.05–16.76 18.02 66.76 60.91 82.13 57.66 83.41 45.56 100.16 110.08 94.46 112.2 70.31 47.87 26.42 14.22 12.78
Lymphocytes K/μL 1.05–5.1 1.01 4.93 3.83 5.35 6.4 8 2.84 22.46 10.1 8.53 14.9 12.63 8.37 2.04 2.13 2.64
Monocytes K/μL 0.16–1.12 2.13 11.11 11.19 4.95 7.58 10.72 1.4 16.63 12.78 7.25 9.07 6.48 4.61 2.4 1.25 1.3
Neutrophils K/μL 2.95–11.64 14.86 50.56 45.79 71.67 34.15 64.45 41.1 60.92 86.93 78.24 87.88 51.06 34.78 19.64 9.72 8.03
Eosinophils K/μL 0.06–1.23 0.01 0.01 0.02 0.02 9.53 0.04 0.01 0.11 0.06 0.07 0.14 0.1 0.05 2.24 0.99 0.74
Basophils K/μL 0–0.1 0.01 0.15 0.08 0.14 0 0.2 0.21 0.04 0.21 0.37 0.21 0.04 0.06 0.1 0.13 0.07
Hematocrit % 37.3–61.7 35.4 40.9 38.9 35.6 38.4 27.3 25 21.7 22.4 9.9 13.7 19.9 24 30.3 36.1 35.8
Red blood cell count M/μL 5.65–8.87 5.75 6.73 6.22 5.94 6.19 4.74 4.27 3.69 3.76 1.71 1.96 2.5 2.93 4.41 5.74 5.88
Hemoglobin g/dL 13.1–20.5 13.3 15.3 14.1 13.4 13.9 10.4 9.3 8.2 8.3 3.7 4.5 6.2 7.7 10.9 13.1 13
Platelets K/μL 148–484 35 99 92 135 13 86 79 37 92 114 197 113 27 392 270 268
Serum biochemical profile
Glucose mg/dL 75–128 100 129 120 122 131 144 127 143 112 105 117 110 93
Blood urea nitrogen mg/dL 7–27 53 49 69 41 38 32 33 26 31 48 27 23 24 16.4 10 13
Creatinine mg/dL 0.5–1.8 2.6 1.7 1.5 1.2 1.1 0.8 0.8 0.7 1 1 0.8 0.8 0.9 0.71 1.5 1.5
Symmetric dimethylarginine μg/dL 0–14 21 41 48 36 35 33 30 26 27 21 30 20 22 17 14 20
Total bililubin mg/dL 0.1–0.5 6.9 24.1 20.6 13.6 20.8 17.6 13.9 13.2 11.6 5.5 4.7 3.4 2.6 0.4
Total protein g/dL 5–7.2 4 4.9 5 4.7
Albumin g/dL 2.6–4 2.8 3.3 2.9 3.1 2.2 3 2.7 3.2 2.9 2 2.5 2.7 2.5
Alanine aminotransaminase IU/L 17–78 237 477 305 291 123 194 196 125 190 246 369 656 762 301 48 47
Alkaline phosphatase IU/L 0–89 1,225 1,225 1,225 1,225 1,225 1,225 1,225 1,225 1,225 1,225 1,225 1,225 1,225 385 115 109
Creatine phosphokinase IU/L 49–166 1219
Calcium mg/dL 9.3–12.1 10.8 10.5 9.8
Inorganic phosphorus mg/dL 1.9–5 7.4 7.5 5 6.1
Lipase IU/L 10–160 66 >1,000 >1,000 829 258 180 326 115 294 149 127 80 92 47 46 52
C-reactive protein mg/dL <0.7 7 7 7 4.5 7 6.8 5.3 5.8 2.1 0.8 1.7 1.7 0.4
The blood coagulation test
Activated partial thromboplastin time Sec 10–16 36.7
Prothrombin time Sec 6–8 8.4
Fibrinogen mg/dL 86–375 374
Fibrinogen degradation product μg/mL 0–5 27.3
Antithrombin activity % 102–156 71
D-Dimer μg/mL 0–2 9.07
Thrombin-antithrombin complex ng/mL 0–0.2 1

On day 4, acute pancreatitis was suspected due to elevated lipase levels (>1,000 IU/L), for which treatment using fuzapladib sodium hydrate (0.4 mg/kg), cefotaxime (50 mg/kg), and buprenorphine (0.015 mg/kg) was started. Appetite normalized on day 7. Ampicillin was changed to minocycline (5 mg/kg) and cefotaxime to meropenem (12 mg/kg) for the treatment of catheter site infection and prevention of secondary infections due to acute pancreatitis, respectively, on day 11. Bowel evacuation normalized on day 18, and the patient was discharged on day 32 because of improvements in appetite and blood examination findings and resolution of vomiting. Upon discharge, faropenem (8 mg/kg) was administered perorally in place of meropenem until day 70 to prevent the recurrence of catheter site infection and pancreatitis. Doxycycline (5 mg/kg) was administered perorally in place of minocycline from day 49 to 70 and again from day 98 to 105 because of mild leukocytosis observed on day 98. Body weight decreased from 25.2 kg on day 0 to 18.8 kg on day 21, but gradually increased to reach 26.6 kg on day 98.

Detailed laboratory tests for leptospirosis were performed at the Okinawa Prefectural Institute of Health and Environment: blood and urine culture using liquid Ellinghausen–McCullough–Johnson–Harris (EMJH) medium, liquid EMJH medium supplemented with sulfamethoxazole, trimethoprim, amphotericin, fosfomycin and 5-fluorouracil (STAFF) [1], and liquid Korthof’s medium; DNA detection for pathogenic Leptospira spp. via nested-PCR targeting the leptospiral gene flaB; and anti-Leptospira antibody detection by microscopic agglutination test (MAT) were conducted as previously described [4, 5]. Blood culture on day 1 and urine culture on Days 1, 9, 11, 14, 18, 23, 26, 29, 32, 44, 62, 77, 91, 119, 146, 175, and 203 were negative. The flaB gene was detected from urine, but not blood, collected on day 1. DNA detection from urine collected on the other days was negative. The nucleotide sequence of the flaB amplicon was determined using the BigDye Terminator v3.1 Cycle Sequencing Kit (Applied Biosystems, Foster City, CA, USA), and the sequence obtained (DDBJ accession number LC713068) was identical to that of L. interrogans (CP044513). Multilocus sequence typing (MLST) of the flaB-positive urine DNA was performed using seven housekeeping genes (glmU, pntA, sucA, tpiA, pfkB, mreA, and caiB) [4, 6, 7], and the sequence type was identified as ST329 (DDBJ accession numbers LC713061-LC713067). This ST has been detected from L. interrogans serogroup Hebdomadis isolated from mongooses and humans in Okinawa, Japan (https://pubmlst.org/organisms/leptospira-spp) [10]. Antibody detection was performed on Days 1, 8, 11, 13, 15, 18, 20, 23, 26, 29, 32, 49, 70, 84, 98, 105, 113, 144, 175, and 203. Anti-Hebdomadis antibodies were seroconverted to reciprocal MAT titer 1,280 on day 8; peaked at 2,560 on Days 11, 13, and 15; and decreased to <40 on day 203 (Fig. 1). Results for culture, DNA detection using blood and urine samples and antibody detection performed at 4 days after the onset of the patient were negative for five dogs living together with the patient and for two dogs who were close contacts at work.

Fig. 1.

Fig. 1.

Change in antibody titers against serogroup Hebdomadis. Antibody detection was performed on Days 1, 8, 11, 13, 15, 18, 20, 23, 26, 29, 32, 49, 70, 84, 98, 105, 113, 144, 175, and 203 by microscopic agglutination test using Leptospira interrogans serovar Hebdomadis strain Akiyami B.

This report describes clinical features and laboratory findings of a mongoose-scat-detection dog infected with L. interrogans. Although culture was not successful, MLST and serological reaction results strongly indicated that the infecting strain was L. interrogans serogroup Hebdomadis. Canine leptospirosis due to infection with L. interrogans serogroup Hebdomadis often occurs in Japan, but its clinical pictures have not been described in detail [6]. Initial manifestations of this case included fever, diarrhea with hematochezia, vomiting, dehydration, and malaise, which are common clinical signs of canine leptospirosis [2]. The patient developed acute renal failure, hepatic dysfunction, and DIC. BUN and creatinine levels are elevated in more than half of leptospirosis cases [9], and successful treatment is associated with a gradual return of the parameters to normal reference ranges within 10–14 days [12]. In the present case, increased serum creatinine and BUN were observed only on day 1 and during the period from day 1 to day 23, respectively, indicating successful treatment. On the other hand, the concentration of SDMA which is a more sensitive biomarker for renal dysfunction than creatinine continued higher than the normal range during the period except day 70, suggesting the renal function of the patient may be impaired even after the recovery. In addition, no sequelae requiring dialysis remained in this case, whereas a previous study showed that approximately 50% of the dogs surviving acute leptospirosis had impaired renal function more than 1 year after hospital discharge [9]. Early antimicrobial therapy is essential to improving the survival rate and duration of hospitalization [2]. Moreover, Leptospira spp. might be shed for months in urine if appropriate antimicrobial treatment is not initiated [12]. The patient in the present case received ampicillin on day 0, which may have contributed to the early recovery of renal function and the removal of L. interrogans from kidney tissue.

In Okinawa Prefecture, small Indian mongooses are invasive species that cause severe damage to native wild animal populations and have thus become the target of capture and extermination. Mongoose-scat-detection dogs play a role in understanding the distribution of mongooses and increasing the efficiency of mongoose capture, with the work performed mainly in forest areas. L. interrogans serogroup Hebdomadis has been isolated from mongooses and mice, and antibodies against serogroup Hebdomadis have been detected in wild boars in the northern part of the main Okinawa Island [3]. In the present case, MLST showed that the patient was infected with L. interrogans ST329, which has been previously isolated from mongooses and humans, suggesting that the patient contracted the disease through the work environment, possibly through fresh water and soil contaminated with mongoose urine.

The patient had been vaccinated with the bivalent vaccine against serovars Canicola and Icterohaemorrhagiae but became infected with the Hebdomadis strain, enforcing the serovar-specific effectiveness of killed whole cell vaccines. Some canine leptospirosis vaccines protect against serogroups Canicola, Icterohaemorrhagiae, Grippotyphosa, and/or Pomona; however, no vaccines are available against serogroups Australis, Autumnalis, and Hebdomadis, which are prevalent in Japan [2, 6, 9, 12]. Among the above serogroups, L. interrogans serogroup Hebdomadis is the most prevalent. A study isolated L. interrogans serogroup Hebdomadis from 21/45 infected dogs (46.7%) and detected antibodies in 34/59 infected dogs (57.6%) [6]. However, canine leptospirosis caused by serogroup Hebdomadis is not listed as a notifiable disease by the Act on Domestic Animal Infectious Diseases Control in Japan. It is necessary to accurately monitor the serological distribution of canine leptospirosis and develop a vaccine suitable for each region.

In conclusion, this report demonstrated that L. interrogans serogroup Hebdomadis infection caused multiple organ dysfunction in a dog. Early diagnosis and early treatment require the identification of specific biomarker(s) for severe canine leptospirosis. In addition, a vaccine tailored according to geographic region or a universal vaccine effective against all serovars is needed for the effective prevention of canine leptospirosis.

CONFLICT OF INTEREST

The authors declare that they have no conflicts of interest.

Acknowledgments

We are grateful to Yoshiteru Murata, Kazuhisa Kameyama, and So Shinya for their comments on this manuscript. This work was partly supported by the Research Program on Emerging and Re-emerging Infectious Diseases (JP22fk0108139) from the Japan Agency for Medical Research and Development (AMED) (NK).

REFERENCES

  • 1.Chakraborty A, Miyahara S, Villanueva SYAM, Saito M, Gloriani NG, Yoshida S. 2011. A novel combination of selective agents for isolation of Leptospira species. Microbiol Immunol 55: 494–501. doi: 10.1111/j.1348-0421.2011.00347.x [DOI] [PubMed] [Google Scholar]
  • 2.Goldstein RE. 2010. Canine leptospirosis. Vet Clin North Am Small Anim Pract 40: 1091–1101. doi: 10.1016/j.cvsm.2010.07.008 [DOI] [PubMed] [Google Scholar]
  • 3.Ishibashi O, Ahagon A, Nakamura M, Morine N, Taira K, Ogura G, Nakachi M, Kawashima Y, Nakada T. 2006. Distribution of Leptospira spp. on the small Asian mongoose and the roof rat inhabiting the northern part of Okinawa island. Jpn J Zoo Wildl Med 11: 35–41. doi: 10.5686/jjzwm.11.35 [DOI] [Google Scholar]
  • 4.Kakita T, Kuba Y, Kyan H, Okano S, Morita M, Koizumi N. 2021. Molecular and serological epidemiology of Leptospira infection in cats in Okinawa Island, Japan. Sci Rep 11: 10365. doi: 10.1038/s41598-021-89872-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Kakita T, Okano S, Kyan H, Miyahira M, Taira K, Kitashoji E, Koizumi N. 2021. Laboratory diagnostic, epidemiological, and clinical characteristics of human leptospirosis in Okinawa Prefecture, Japan, 2003-2020. PLoS Negl Trop Dis 15: e0009993. doi: 10.1371/journal.pntd.0009993 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Koizumi N, Muto MM, Akachi S, Okano S, Yamamoto S, Horikawa K, Harada S, Funatsumaru S, Ohnishi M. 2013. Molecular and serological investigation of Leptospira and leptospirosis in dogs in Japan. J Med Microbiol 62: 630–636. doi: 10.1099/jmm.0.050039-0 [DOI] [PubMed] [Google Scholar]
  • 7.Koizumi N, Muto MM, Izumiya H, Suzuki M, Ohnishi M. 2015. Multiple-locus variable-number tandem repeat analysis and clinical characterization of Leptospira interrogans canine isolates. J Med Microbiol 64: 288–294. doi: 10.1099/jmm.0.000027 [DOI] [PubMed] [Google Scholar]
  • 8.Levett PN. 2001. Leptospirosis. Clin Microbiol Rev 14: 296–326. doi: 10.1128/CMR.14.2.296-326.2001 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Schuller S, Francey T, Hartmann K, Hugonnard M, Kohn B, Nally JE, Sykes J. 2015. European consensus statement on leptospirosis in dogs and cats. J Small Anim Pract 56: 159–179. doi: 10.1111/jsap.12328 [DOI] [PubMed] [Google Scholar]
  • 10.Shinya S, Muraoka Y, Negishi D, Koizumi N. 2021. Molecular epidemiology of Leptospira spp. among wild mammals and a dog in Amami Oshima Island, Japan. PLoS One 16: e0249987. doi: 10.1371/journal.pone.0249987 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Slack AT, Symonds ML, Dohnt MF, Smythe LD. 2006. Identification of pathogenic Leptospira species by conventional or real-time PCR and sequencing of the DNA gyrase subunit B encoding gene. BMC Microbiol 6: 95. doi: 10.1186/1471-2180-6-95 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Sykes JE, Hartmann K, Lunn KF, Moore GE, Stoddard RA, Goldstein RE. 2011. 2010 ACVIM small animal consensus statement on leptospirosis: diagnosis, epidemiology, treatment, and prevention. J Vet Intern Med 25: 1–13. doi: 10.1111/j.1939-1676.2010.0654.x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Vincent AT, Schiettekatte O, Goarant C, Neela VK, Bernet E, Thibeaux R, Ismail N, Mohd Khalid MKN, Amran F, Masuzawa T, Nakao R, Amara Korba A, Bourhy P, Veyrier FJ, Picardeau M. 2019. Revisiting the taxonomy and evolution of pathogenicity of the genus Leptospira through the prism of genomics. PLoS Negl Trop Dis 13: e0007270. doi: 10.1371/journal.pntd.0007270 [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from The Journal of Veterinary Medical Science are provided here courtesy of Japanese Society of Veterinary Science

RESOURCES